US Patent 10604522 Processes for producing diazabicyclooctane compounds
Patent 10604522 was granted and assigned to Meiji Seika Pharma on March, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
106045220
Date of Patent
March 31, 2020
0Patent Application Number
161487740
Date Filed
October 1, 2018
0Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 2 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10604522 Processes for producing diazabicyclooctane compounds
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10604522
Date of patent
March 31, 2020
Patent application number
16148774
Date Filed
October 1, 2018
Patent primary examiner
Find more entities like US Patent 10604522 Processes for producing diazabicyclooctane compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
